Prospective study on cost-effectiveness of home-based motor assessment in Parkinson’s disease

Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients

(2014) Christofer Lundqvist et al.   JOURNAL OF NEUROLOGY

Clinician versus machine: Reliability and responsiveness of motor endpoints in Parkinson's disease

(2014) Dustin A. Heldman et al.   PARKINSONISM & RELATED DISORDERS

Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease

(2013) Richard Dodel et al.   MOVEMENT DISORDERS

A short Scale for Evaluation of Neuropsychiatric Disorders in Parkinson’s Disease: first psychometric approach

(2012) Pablo Martinez-Martin et al.   JOURNAL OF NEUROLOGY

Methods and issues associated with the use of quality-adjusted life-years

(2012) Dennis A Revicki et al.   Expert Review of Pharmacoeconomics & Outcomes Research

The modified bradykinesia rating scale for Parkinson's disease: Reliability and comparison with kinematic measures

(2011) Dustin A. Heldman et al.   MOVEMENT DISORDERS

Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease

(2011) Alberto J. Espay et al.   MOVEMENT DISORDERS

Comparison of office-based versus home web-based clinical assessments for Parkinson's disease

(2011) Esther Cubo et al.   MOVEMENT DISORDERS

Costs of illness and care in Parkinson's Disease: An evaluation in six countries

(2010) Sonja von Campenhausen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

Clinically deployable Kinesia™ technology for automated tremor assessment

(2009) Joseph P. Giuffrida et al.   MOVEMENT DISORDERS